Trials / Completed
CompletedNCT00161915
Efficacy and Safety of Endoscopic Injection of Fibrin Sealant Versus Endoscopic Ligature for Bleeding Esophageal Varices
Prospective Randomized Study on the Efficacy of Endoscopic Injection Therapy With Fibrin Sealant Versus Endoscopic Ligature for Acute Hemostasis and the Prophylaxis of Recurrent Bleeding From Esophageal Varices
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- Baxter Healthcare Corporation · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- —
Summary
The purpose of this study was to assess whether endoscopic sclerotherapy with Fibrin Sealant was superior to ligature, with or without Polidocanol, in achieving hemostasis in bleeding esophageal varices and preventing rebleeding. Therapeutic success was defined as survival of the first seven days without clinically significant bleeding.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Fibrin Sealant |
Timeline
- Start date
- 2000-12-01
- Completion
- 2004-01-01
- First posted
- 2005-09-13
- Last updated
- 2006-10-23
Locations
12 sites across 1 country: Germany
Source: ClinicalTrials.gov record NCT00161915. Inclusion in this directory is not an endorsement.